Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06598111 · ClinicalTrials.gov registry record · NA

Increasing Motivation to Reduce Restriction

A NA study, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
126
Enrollment target

NCT06598111: Completed NA study, sponsored by Florida State University.

NCT06598111 is a NA study that has completed, run by Florida State University. The registered enrollment target is 126 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06598111, a NA study, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
126 participants
Enrollment target

Study Summary

The goal of this experiment is to learn how to effectively increase motivation to reduce dietary restriction among young adults engaging in clinically significant restrictive eating. The main questions this study aims to answer are: * Does imagining a future without restrictive eating increase motivation to reduce restrictive eating? * Does imagining a future without restrictive eating reduce actual restrictive eating behavior? * Is it more motivating to think about long-term benefits of reducing dietary restriction, or to focus on short-term consequences of dietary restriction? Researchers will compare (1) amplifying the possible benefits of reducing restrictive eating, (2) amplifying the negative consequences of restrictive eating, or (3) both is more effective for increasing motivation to reduce dietary restriction over a one-week period. Participants will: * Complete daily measures of eating disorder symptoms and motivation for 7 days * Write a narrative describing a day in the future without restrictive eating and read this narrative aloud daily for 7 days * Be presented with information regarding the negative consequences of dietary restriction daily for 7 days

Primary Outcome

Dietary restraint was measured using two items drawn from the Eating Disorder Examination Questionnaire. Each item was rated on a 1-6 scale ranging from 1 (Not at all/never) to 6 (Markedly/all the time). Scores on each item were averaged to create a single dietary restraint score. Changes in daily scores were used to quantify changes in dietary restraint over time.

Interventions

  • OTHER Control
  • OTHER Amplified Benefits
  • OTHER Amplified Consequences

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2023-01-18
Est. Completion 2024-03-05
Phase NA
Florida State University

219 total trials

What the finished NCT06598111 record still lists

NCT06598111 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.

NCT06598111 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06598111 about?

NCT06598111 is a clinical study titled "Increasing Motivation to Reduce Restriction". The goal of this experiment is to learn how to effectively increase motivation to reduce dietary restriction among young adults engaging in clinically significant restrictive eating. The main questions this study aims to answer are: * Does imagining a future without restrictive eating increase moti...

What is the current status of trial NCT06598111?

This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2023-01-18. Estimated completion is 2024-03-05.

What interventions are being tested in trial NCT06598111?

The interventions under investigation include: Control (OTHER), Amplified Benefits (OTHER), Amplified Consequences (OTHER).

Who is sponsoring clinical trial NCT06598111?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06598111's enrollment target sits among peer trials

126 749th of 2000 higher than 1,248 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01873131 · 126 participants · NA

    A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

  • NCT02621645 · 126 participants · Phase 4

    TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

  • NCT03838107 · 126 participants

    Markers of Trajectory in Pediatric CRPS

  • NCT03906422 · 126 participants · NA

    Comparison of Patient-reported Pain After Initial Archwire Placement

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06598111, the US trial registry maintained by the National Library of Medicine. NCT06598111 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.